FDA Approved: ACARBOSE — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

FDA approves a supplemental application for acarbose (generic) filed by Chartwell RX, LLC under ANDA 202271.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Acarbose (acarbose)

Snippet

SUPPL AP for ACARBOSE (ACARBOSE)